Ramirez Faustine D, Groner Judith A, Ramirez Joel L, McEvoy Cindy T, Owens Judith A, McCulloch Charles E, Cabana Michael D, Abuabara Katrina
Department of Pediatrics, University of California, San Francisco (FD Ramirez).
Julius B. Richmond Center of Excellence, American Academy of Pediatrics (JA Groner), Itasca, Ill; Department of Pediatrics, Nationwide Children's Hospital (JA Groner), Columbus, Ohio.
Acad Pediatr. 2021 May-Jun;21(4):654-662. doi: 10.1016/j.acap.2020.11.003. Epub 2020 Nov 5.
To determine whether prenatal and childhood tobacco smoke exposure (TSE) are each independently associated with mild sleep-disordered breathing (SDB) symptoms throughout early childhood, and whether the association between childhood TSE and SDB differs according to the level of prenatal exposure.
Longitudinal cohort study, using data from the Avon Longitudinal Study of Parents and Children, a population-based birth cohort from the United Kingdom. Primary exposures were repeated measures of mother-reported prenatal and childhood TSE through age 7 years. Outcomes were mother-reported measures of mild SDB symptoms, including snoring, mouth breathing, and witnessed apnea, repeated annually through age 7 years.
A total of 12,030 children were followed for a median duration of 7 years. About 24.2% were exposed to prenatal tobacco smoke, 46.2% were exposed at least once in childhood, and 20.6% were exposed during both periods. Both prenatal and childhood TSE were associated with SDB symptoms throughout early childhood (adjusted OR [aOR] for any prenatal TSE 1.23; 95% confidence interval [CI] 1.08, 1.40; aOR for any childhood TSE 1.17; 95% CI 1.06, 1.29). We observed a dose-response effect between TSE and SBD symptoms, and found evidence of effect modification for those exposed during both time periods (combined high level exposure both prenatally and during childhood: aOR snoring 2.43 [95% CI 1.50, 3.93], aOR apnea 2.65 [95% CI 1.46, 4.82]).
Prenatal and childhood TSE were both independently associated with mild SDB symptoms throughout early childhood in a dose-dependent manner, further supporting the critical importance of maintaining a tobacco-free environment throughout gestation and childhood.
确定产前和儿童期烟草烟雾暴露(TSE)是否分别与幼儿期轻度睡眠呼吸障碍(SDB)症状独立相关,以及儿童期TSE与SDB之间的关联是否因产前暴露水平而异。
纵向队列研究,使用来自英国基于人群的出生队列“雅芳亲子纵向研究”的数据。主要暴露因素是母亲报告的产前和儿童期TSE的重复测量数据,直至7岁。结局指标是母亲报告的轻度SDB症状测量值,包括打鼾、口呼吸和观察到的呼吸暂停,每年重复测量,直至7岁。
共对12,030名儿童进行了中位时长为7年的随访。约24.2%的儿童有产前烟草烟雾暴露,46.2%的儿童在儿童期至少有一次暴露,20.6%的儿童在两个时期均有暴露。产前和儿童期TSE均与幼儿期的SDB症状相关(任何产前TSE的调整后比值比[aOR]为1.23;95%置信区间[CI]为1.08, 1.40;任何儿童期TSE的aOR为1.17;95% CI为1.06, 1.29)。我们观察到TSE与SBD症状之间存在剂量反应效应,并发现两个时期均暴露的儿童存在效应修正的证据(产前和儿童期均为高水平暴露:打鼾的aOR为2.43 [95% CI 1.50, 3.93],呼吸暂停的aOR为2.65 [95% CI 1.46, 4.82])。
产前和儿童期TSE均与幼儿期轻度SDB症状独立相关,且呈剂量依赖性,进一步支持了在整个孕期和儿童期保持无烟环境的至关重要性。